Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

8 results
Display

Discharge Planning for Elderly Diabetic Patients

Cho SH

As the elderly population increases, the importance of treatment and management of elderly diabetic patients is also growing. Diabetes is a disease for which self-management is important; diabetes educators form...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Early-Onset Type 2 Diabetes

Kim JH

Early-onset type 2 diabetes is experiencing a rapid global increase, coinciding with the escalating rates of obesity. In contrast to diagnoses later in life, an earlier diagnosis is associated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Global Shortage of Glucagon-Like Peptide-1 Receptor Agonists

Yi D

The global shortage of glucagon-like peptide-1 (GLP-1) receptor agonists, which are highly sought after as treatments for type 2 diabetes and obesity, is increasing. This deficit is attributed to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning

Lim JH

Nutrition therapy is plays a pivotal role in diabetes prevention and blood glucose control among diabetics. The contents of the revision of the food exchange lists are as follows. First,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
SGLT2 Inhibitors and Diabetes: Where Does It Come from and Where Does It Go?

Kim JY, Kim SG

Sodium glucose cotransporter 2 (SGLT2) inhibitors have emerged as powerful medications in the past decade. Numerous clinical trials have reported their cardio-renal protective effects and associated reductions in mortality. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevention of Diabetic Foot and Treatment of Pre-Ulcerative Signs

Son JW

Diabetes is one of the most prevalent chronic conditions and is expected to affect nearly 800 million people worldwide by 2045. Diabetes entails many complications; diabetic foot is among the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chronic Kidney Disease and SGLT2 Inhibitors

Koh ES, Chung S

Sodium glucose cotransporter 2 (SGLT2) inhibitors were initially developed to enhance glycemic control in diabetic patients, but they have emerged as a promising treatment for individuals with chronic kidney disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
SGLT2 Inhibitors in the Cardiovascular Disease

Park JJ

Sodium glucose cotransporter 2 (SGLT2) inhibitors, initially designed for type 2 diabetes management, have exhibited consistent efficacy across the cardiovascular disease continuum. Their benefits are experienced by patients with cardiovascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr